Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 2
Real-world experience in treatment of patients with non-small-cell lung cancer with BRAF or cMET exon 14 skipping mutations
Urška Janžič, Walid Shalata, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopović, Giannis Mountzios, Adam Płużański, António Araújo, Andriani Charpidou, Abed Agbarya
Izvirni znanstveni članek
Oznake: nedrobnocelični pljučni rak;mutacija BRAF V600;podatki iz resničnega življenja;tarčna terapija;zdravljenje prvega reda;non-small-cell lung cancer;BRAF V600 mutation;cMET exon 14 skipping mutation;real-world data;targeted therapy;first-line therapy;
BRAF and cMET exon 14 skipping are rare mutations of NSCLC. The treatment sequence in these cases for the first and second line is not clear. An international registry was created for patients with advanced NSCLC harboring BRAF or cMET exon 14 skipping mutations, diagnosed from January 2017 to June ...
Leto: 2023 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC
Alfredo Addeo, Maximilian J Hochmair, Urška Janžič, Elizabeth Dudnik, Andriani Charpidou, Adam Płużański, Tudor Ciuleanu, Ivan Shterev Donev, Judith Elbaz, Jørgen Aarøe, René Ott, Nir Peled
Izvirni znanstveni članek
Oznake: napredovali nedrobnocelinčni karcinom pljuč;podatki iz resničnega življenja;srednja Evropa;advanced non-small cell lung cancer;real-world data;Central Europe;
Background. Immunotherapy with immune checkpoint inhibitors (ICIs) recently became the standard treatment for patients with advanced non-small cell lung cancer (NSCLC). Here, we present the first results of a real-world observational study on the effectiveness of ICI monotherapy in patients with adv ...
Leto: 2021 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Št. zadetkov: 2
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: